S&P 500   3,861.35 (+0.16%)
DOW   31,033.83 (+0.24%)
QQQ   328.85 (+0.23%)
AAPL   142.44 (-0.34%)
MSFT   233.07 (+1.54%)
FB   282.62 (+1.66%)
GOOGL   1,899.02 (+0.25%)
AMZN   3,317.52 (+0.71%)
TSLA   884.10 (+0.37%)
NVDA   542.99 (-0.57%)
BABA   262.36 (+0.37%)
CGC   35.47 (+7.78%)
GE   11.68 (+6.28%)
MU   81.64 (+0.44%)
AMD   95.21 (+1.15%)
NIO   59.32 (-1.12%)
T   29.39 (+0.96%)
F   11.32 (+0.27%)
ACB   10.74 (+5.71%)
BA   203.22 (-0.07%)
DIS   170.35 (-0.90%)
NFLX   563.12 (+1.14%)
GILD   67.02 (-1.67%)
S&P 500   3,861.35 (+0.16%)
DOW   31,033.83 (+0.24%)
QQQ   328.85 (+0.23%)
AAPL   142.44 (-0.34%)
MSFT   233.07 (+1.54%)
FB   282.62 (+1.66%)
GOOGL   1,899.02 (+0.25%)
AMZN   3,317.52 (+0.71%)
TSLA   884.10 (+0.37%)
NVDA   542.99 (-0.57%)
BABA   262.36 (+0.37%)
CGC   35.47 (+7.78%)
GE   11.68 (+6.28%)
MU   81.64 (+0.44%)
AMD   95.21 (+1.15%)
NIO   59.32 (-1.12%)
T   29.39 (+0.96%)
F   11.32 (+0.27%)
ACB   10.74 (+5.71%)
BA   203.22 (-0.07%)
DIS   170.35 (-0.90%)
NFLX   563.12 (+1.14%)
GILD   67.02 (-1.67%)
S&P 500   3,861.35 (+0.16%)
DOW   31,033.83 (+0.24%)
QQQ   328.85 (+0.23%)
AAPL   142.44 (-0.34%)
MSFT   233.07 (+1.54%)
FB   282.62 (+1.66%)
GOOGL   1,899.02 (+0.25%)
AMZN   3,317.52 (+0.71%)
TSLA   884.10 (+0.37%)
NVDA   542.99 (-0.57%)
BABA   262.36 (+0.37%)
CGC   35.47 (+7.78%)
GE   11.68 (+6.28%)
MU   81.64 (+0.44%)
AMD   95.21 (+1.15%)
NIO   59.32 (-1.12%)
T   29.39 (+0.96%)
F   11.32 (+0.27%)
ACB   10.74 (+5.71%)
BA   203.22 (-0.07%)
DIS   170.35 (-0.90%)
NFLX   563.12 (+1.14%)
GILD   67.02 (-1.67%)
S&P 500   3,861.35 (+0.16%)
DOW   31,033.83 (+0.24%)
QQQ   328.85 (+0.23%)
AAPL   142.44 (-0.34%)
MSFT   233.07 (+1.54%)
FB   282.62 (+1.66%)
GOOGL   1,899.02 (+0.25%)
AMZN   3,317.52 (+0.71%)
TSLA   884.10 (+0.37%)
NVDA   542.99 (-0.57%)
BABA   262.36 (+0.37%)
CGC   35.47 (+7.78%)
GE   11.68 (+6.28%)
MU   81.64 (+0.44%)
AMD   95.21 (+1.15%)
NIO   59.32 (-1.12%)
T   29.39 (+0.96%)
F   11.32 (+0.27%)
ACB   10.74 (+5.71%)
BA   203.22 (-0.07%)
DIS   170.35 (-0.90%)
NFLX   563.12 (+1.14%)
GILD   67.02 (-1.67%)
Log in
NASDAQ:CUTR

Cutera Stock Forecast, Price & News

$26.91
-0.04 (-0.15 %)
(As of 01/26/2021 10:37 AM ET)
Add
Compare
Today's Range
$26.52
Now: $26.91
$26.91
50-Day Range
$20.86
MA: $23.44
$27.54
52-Week Range
$9.07
Now: $26.91
$29.56
Volume264 shs
Average Volume110,777 shs
Market Capitalization$474.50 million
P/E RatioN/A
Dividend YieldN/A
Beta1.6
Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, and myQ products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.
Cutera logo

MarketRank

Overall MarketRank

1.25 out of 5 stars

Computer And Technology Sector

472nd out of 1,501 stocks

Electromedical Equipment Industry

19th out of 61 stocks

Analyst Opinion: 1.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
Current SymbolNASDAQ:CUTR
CUSIPN/A
Phone415-657-5500
Employees447
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$181.71 million
Book Value$3.23 per share

Profitability

Net Income$-12,350,000.00

Miscellaneous

Market Cap$474.50 million
Next Earnings Date2/24/2021 (Estimated)
OptionableOptionable
$26.91
-0.04 (-0.15 %)
(As of 01/26/2021 10:37 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CUTR News and Ratings via Email

Sign-up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cutera (NASDAQ:CUTR) Frequently Asked Questions

How has Cutera's stock price been impacted by COVID-19 (Coronavirus)?

Cutera's stock was trading at $18.11 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CUTR shares have increased by 48.6% and is now trading at $26.91.
View which stocks have been most impacted by COVID-19
.

Is Cutera a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cutera stock.
View analyst ratings for Cutera
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Cutera?

Wall Street analysts have given Cutera a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cutera wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera CEO David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among Cutera's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Cutera's next earnings date?

Cutera is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Cutera
.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) announced its earnings results on Wednesday, November, 4th. The medical device company reported ($0.13) EPS for the quarter, topping the Zacks' consensus estimate of ($0.42) by $0.29. The medical device company earned $39.13 million during the quarter, compared to analyst estimates of $35.10 million. Cutera had a negative net margin of 18.83% and a negative trailing twelve-month return on equity of 61.21%.
View Cutera's earnings history
.

What price target have analysts set for CUTR?

4 analysts have issued 12-month target prices for Cutera's shares. Their forecasts range from $24.00 to $28.00. On average, they anticipate Cutera's share price to reach $26.00 in the next year. This suggests that the stock has a possible downside of 3.4%.
View analysts' price targets for Cutera
or view Wall Street analyst' top-rated stocks.

Are investors shorting Cutera?

Cutera saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 598,700 shares, an increase of 38.3% from the December 15th total of 433,000 shares. Based on an average daily trading volume, of 139,800 shares, the short-interest ratio is currently 4.3 days.
View Cutera's Short Interest
.

Who are some of Cutera's key competitors?

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Square (SQ) and Twilio (TWLO).

Who are Cutera's key executives?

Cutera's management team includes the following people:
  • Mr. David H. Mowry, CEO & Director (Age 58, Pay $751.41k)
  • Mr. R. Jason Richey, Pres (Age 46, Pay $1.02M)
  • Mr. Rohan Seth, Chief Financial Officer
  • Dr. Michael Karavitis, Exec. VP & Chief Technology Officer
  • Mr. Matthew Scalo, VP of Investor Relations & Corp. Devel.
  • Tanya Rodante, Director of Corp. Communications
  • Mr. Rajesh Madan, VP of Fin.

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Who are Cutera's major shareholders?

Cutera's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.08%). Company insiders that own Cutera stock include David H Mowry, J Daniel Plants and Katherine S Zanotti.
View institutional ownership trends for Cutera
.

Which institutional investors are selling Cutera stock?

CUTR stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue.
View insider buying and selling activity for Cutera
or view top insider-selling stocks.

How do I buy shares of Cutera?

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $26.91.

How big of a company is Cutera?

Cutera has a market capitalization of $474.50 million and generates $181.71 million in revenue each year. The medical device company earns $-12,350,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis. Cutera employs 447 workers across the globe.

What is Cutera's official website?

The official website for Cutera is www.cutera.com.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.